TREM-1 as a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma

被引：0
|
作者：
Yaling Pu
Danyang Cai
Lingling Jin
Fenfen Xu
Enru Ye
Lina Wu
Licai Mo
Suzhi Liu
Qunyi Guo
Gang Wu
机构：
[1] Taizhou Hospital of Zhejiang Province,Department of Radiation Oncology
[2] Shao Xing University,Department of Pathology
[3] Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University,Department of Pharmacy
[4] Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University,Department of Pathology
[5] Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University,Department of Urology
[6] Enze Hospital,Department of Neurology
[7] Taizhou Enze Medical Center,Department of Hematology and Oncology
[8] Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University,undefined
[9] Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University,undefined
[10] Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University,undefined
来源：
World Journal of Surgical Oncology | / 21卷
关键词：
Immune-related signature; Clear cell renal cell carcinoma; The Cancer Genome Atlas; Tumor immune microenvironment; TREM-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] TREM-1 as a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma
    Pu, Yaling
    Cai, Danyang
    Jin, Lingling
    Xu, Fenfen
    Ye, Enru
    Wu, Lina
    Mo, Licai
    Liu, Suzhi
    Guo, Qunyi
    Wu, Gang
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [2] CHEK2 is a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma
    Qihang Wu
    Cheng Fang
    Xue Wang
    Shuaishuai Huang
    Guobin Weng
    [J]. Scientific Reports, 13
  • [3] CHEK2 is a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma
    Wu, Qihang
    Fang, Cheng
    Wang, Xue
    Huang, Shuaishuai
    Weng, Guobin
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [4] ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma
    Zhang, Chiyu
    Hu, Honglin
    Huang, Ruizhen
    Huang, Gaomin
    Xi, Xiaoqing
    [J]. FRONTIERS IN SURGERY, 2022, 9
  • [5] MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma
    Fang, Jiayu
    Zhen, Jing
    Gong, Yiyang
    Ke, Yun
    Fu, Bidong
    Jiang, Yike
    Xie, Jing
    Liu, Yue
    Ding, Yongqi
    Huang, Da
    Xiao, Fan
    [J]. AGING-US, 2022, 14 (18): : 7416 - 7442
  • [6] CRYL1 is a Potential Prognostic Biomarker of Clear Cell Renal Cell Carcinoma Correlated with Immune Infiltration and Cuproptosis
    Li, Peng
    Xu, Qiangqiang
    Liu, Ken
    Ye, Junjie
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [7] HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration
    Zhang, Fan
    Yuan, DongBo
    Song, JuKun
    Chen, WeiMing
    Wang, Wei
    Zhu, GuoHua
    Hu, Bin
    Chen, Xiaoyue
    Zhu, Jianguo
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [8] CLDN10 associated with immune infiltration is a novel prognostic biomarker for clear cell renal cell carcinoma
    Yang, Wuping
    Li, Lei
    Zhang, Kenan
    Ma, Kaifang
    Gong, Yanqing
    Zhou, Jingcheng
    Gong, Kan
    [J]. EPIGENOMICS, 2021, 13 (01) : 31 - 45
  • [9] POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma
    Tian, Junjie
    Cheng, Cheng
    Gao, Jianguo
    Fu, Guanghou
    Xu, Zhijie
    Chen, Xiaoyi
    Wu, Yunfei
    Jin, Baiye
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [10] SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma
    Feng, Huayi
    Wang, Tao
    Ye, Jiali
    Yang, Yang
    Huang, Xing
    Lai, Dong
    Lv, Zheng
    Huang, Yan
    Zhang, Xu
    [J]. DISCOVER ONCOLOGY, 2022, 13 (01)
12345